KEY TAKEAWAY: Biotech companies that transform themselves into big pharma on the strength of one or two drugs are destined to fail if they forget what made them great. Biogen was a small biotech company who fancied themselves as a player in the big pharma arena. Now, in all likelihood, they are going to be bought.
- New products are being launched with heavy TV but product websites remain relatively unchanged.
- A report from Tel Aviv-based cybersecurity firm Cheq says up to 20% of ad dollars
isbeing stolen through digital ad fraud.
- With more consolidation within pharma vendors bigger agencies are more likely to recommend TV as opposed to digital but this is a serious mistake